Conference

Conferences is a vertical on Op-Med that features overarching coverage of conferences as well as breakdowns of studies presented at conferences.

featured article image

2026 Conference Coverage

Featured Article

Read ASN Kidney Week 2026 Highlights

Link to Mohamed Atta, MD's page

ASN Kidney Week 2026 Highlights

Mohamed Atta, MD

Nov 2, 2026 Link to ASN Kidney Week 2026 Highlights

Read When Kidney Week’s AI Conversation Shifted From Prediction to Practice

Link to Wisit Cheungpasitporn, MD's page

When Kidney Week’s AI Conversation Shifted From Prediction to Practice

Wisit Cheungpasitporn, MD

Nov 2, 2026 Link to When Kidney Week’s AI Conversation Shifted From Prediction to Practice

Read IgA Nephropathy; So Many Options for Treatment!

Link to Adam Bregman, MD's page

IgA Nephropathy; So Many Options for Treatment!

Adam Bregman, MD

Nov 2, 2026 Link to IgA Nephropathy; So Many Options for Treatment!

Read What Survived the Hazard Ratios at ESMO 2026

Link to Arturo Loaiza-Bonilla, MD's page

What Survived the Hazard Ratios at ESMO 2026

Arturo Loaiza-Bonilla, MD

Nov 2, 2026 Link to What Survived the Hazard Ratios at ESMO 2026

Read Atacicept Stops Loss of Kidney Function in IgA Nephropathy

Link to Roxanne Nelson, RN, BSN's page

Atacicept Stops Loss of Kidney Function in IgA Nephropathy

Roxanne Nelson, RN, BSN

Nov 2, 2026 Link to Atacicept Stops Loss of Kidney Function in IgA Nephropathy

Read Vadadustat Thrice Weekly Improves Clinical Outcomes vs Epo in Dialysis Patients With Renal Anemia

Link to Roxanne Nelson, RN, BSN's page

Vadadustat Thrice Weekly Improves Clinical Outcomes vs Epo in Dialysis Patients With Renal Anemia

Roxanne Nelson, RN, BSN

Nov 2, 2026 Link to Vadadustat Thrice Weekly Improves Clinical Outcomes vs Epo in Dialysis Patients With Renal Anemia

Read Nous-209, a Neoantigen Vaccine for Cancer Intervention in Lynch Syndrome Is Safe and Immunogenic

Link to Lynne Lederman, PhD's page

Nous-209, a Neoantigen Vaccine for Cancer Intervention in Lynch Syndrome Is Safe and Immunogenic

Lynne Lederman, PhD

Nov 2, 2026 Link to Nous-209, a Neoantigen Vaccine for Cancer Intervention in Lynch Syndrome Is Safe and Immunogenic

Read Dostarlimab May Allow Patients With dMMR/MSI-H Locally Advanced Rectal Cancer To Avoid Surgery, Chemotherapy, and Radiation

Link to Lynne Lederman, PhD's page

Dostarlimab May Allow Patients With dMMR/MSI-H Locally Advanced Rectal Cancer To Avoid Surgery, Chemotherapy, and Radiation

Lynne Lederman, PhD

Nov 2, 2026 Link to Dostarlimab May Allow Patients With dMMR/MSI-H Locally Advanced Rectal Cancer To Avoid Surgery, Chemotherapy, and Radiation

Read Starting HPV Vaccination at Ages 9-10 Raised Completion by Age 13 in Cluster Randomized Trial

Link to Christos Evangelou, MSc, PhD's page

Starting HPV Vaccination at Ages 9-10 Raised Completion by Age 13 in Cluster Randomized Trial

Christos Evangelou, MSc, PhD

Oct 31, 2026 Link to Starting HPV Vaccination at Ages 9-10 Raised Completion by Age 13 in Cluster Randomized Trial

Read Real-World Data Show 1% Confirmed Virologic Failure With Long-Acting Cabotegravir/Rilpivirine Over 5 Years

Link to Christos Evangelou, MSc, PhD's page

Real-World Data Show 1% Confirmed Virologic Failure With Long-Acting Cabotegravir/Rilpivirine Over 5 Years

Christos Evangelou, MSc, PhD

Oct 30, 2026 Link to Real-World Data Show 1% Confirmed Virologic Failure With Long-Acting Cabotegravir/Rilpivirine Over 5 Years

Read 2026 Safar Symposium: The Health System Is the Patient

Link to Christopher Horvat, MD's page

2026 Safar Symposium: The Health System Is the Patient

Christopher Horvat, MD

Oct 29, 2026 Link to 2026 Safar Symposium: The Health System Is the Patient

Read Gene Therapy for Vestibular Schwannoma: Initial Safety Results From the AK-antiVEGF-101 Trial

Link to Christos Evangelou, MSc, PhD's page

Gene Therapy for Vestibular Schwannoma: Initial Safety Results From the AK-antiVEGF-101 Trial

Christos Evangelou, MSc, PhD

Oct 26, 2026 Link to Gene Therapy for Vestibular Schwannoma: Initial Safety Results From the AK-antiVEGF-101 Trial

Read CHORD trial: Gene Therapy for Otoferlin-Related Deafness Shows Hearing and Early Speech Gains in Children

Link to Christos Evangelou, MSc, PhD's page

CHORD trial: Gene Therapy for Otoferlin-Related Deafness Shows Hearing and Early Speech Gains in Children

Christos Evangelou, MSc, PhD

Oct 26, 2026 Link to CHORD trial: Gene Therapy for Otoferlin-Related Deafness Shows Hearing and Early Speech Gains in Children

Read The Earlier the Better: Effective Intervention to Prevent Crohn’s Disease Progression

Link to Stephen B Hanauer, MD's page

The Earlier the Better: Effective Intervention to Prevent Crohn’s Disease Progression

Stephen B Hanauer, MD

Oct 19, 2026 Link to The Earlier the Better: Effective Intervention to Prevent Crohn’s Disease Progression

Read ACG 2026: Women With IBD Have a High Rate of Success With Fertility Treatments

Link to Todd Neale's page

ACG 2026: Women With IBD Have a High Rate of Success With Fertility Treatments

Oct 19, 2026 Link to ACG 2026: Women With IBD Have a High Rate of Success With Fertility Treatments

Read REMODEL: Dupilumab Increases Esophageal Distensibility in EoE

Link to Todd Neale's page

REMODEL: Dupilumab Increases Esophageal Distensibility in EoE

Oct 19, 2026 Link to REMODEL: Dupilumab Increases Esophageal Distensibility in EoE

Read PREVAIL Analysis Reveals Broad Benefits of Gefurulimab in Generalized Myasthenia Gravis

Link to Todd Neale's page

PREVAIL Analysis Reveals Broad Benefits of Gefurulimab in Generalized Myasthenia Gravis

Oct 12, 2026 Link to PREVAIL Analysis Reveals Broad Benefits of Gefurulimab in Generalized Myasthenia Gravis

Read Efgartigimod Benefits Patients With Generalized Myasthenia Gravis Without Anti-AChR Antibodies

Link to Todd Neale's page

Efgartigimod Benefits Patients With Generalized Myasthenia Gravis Without Anti-AChR Antibodies

Oct 12, 2026 Link to Efgartigimod Benefits Patients With Generalized Myasthenia Gravis Without Anti-AChR Antibodies

Read What I've Learned at Conferences as a Medical Student

Link to Sara Perelmuter's page

What I've Learned at Conferences as a Medical Student

Sara Perelmuter

Jul 20, 2026 Link to What I've Learned at Conferences as a Medical Student

Read Retatrutide Reduces Body Weight by Nearly 30% in Phase 3 TRIUMPH-1 Trial, With Gains for Sleep Apnea and Knee Pain

Link to Christos Evangelou, MSc, PhD's page

Retatrutide Reduces Body Weight by Nearly 30% in Phase 3 TRIUMPH-1 Trial, With Gains for Sleep Apnea and Knee Pain

Christos Evangelou, MSc, PhD

Jun 16, 2026 Link to Retatrutide Reduces Body Weight by Nearly 30% in Phase 3 TRIUMPH-1 Trial, With Gains for Sleep Apnea and Knee Pain

Read Orforglipron Outperforms Dapagliflozin on HbA1c and Weight in Type 2 Diabetes Trial ACHIEVE-2

Link to Christos Evangelou, MSc, PhD's page

Orforglipron Outperforms Dapagliflozin on HbA1c and Weight in Type 2 Diabetes Trial ACHIEVE-2

Christos Evangelou, MSc, PhD

Jun 16, 2026 Link to Orforglipron Outperforms Dapagliflozin on HbA1c and Weight in Type 2 Diabetes Trial ACHIEVE-2